Outcomes11

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 11 of 11

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Change in Muscle Sympathetic Nerve Activity Responses During Hypoxia	baseline and 6 weeks	Data is for fewer subjects than were randomized to treatment because a useable nerve signal was not obtained on all participants.	bursts/minute*%SaO2	MEAN
SECONDARY	Change in Aortic Pulse Wave Velocity	baseline and 6 weeks	Since this was a secondary outcome measure, not all participants were able to undergo this procedure since scheduling did not always allow with scheduling for primary outcome measure.	m/s	MEAN
SECONDARY	Cerebrovascular Conductance	baseline and 6 weeks	Since this was a secondary outcome measure, not all participants were able to undergo this procedure since scheduling did not always allow with scheduling for primary outcome measure.	cm/sec/mmHg	MEAN
SECONDARY	Forearm Vascular Conductance	baseline and 6 weeks	Participants were not able to conduct all procedures due to scheduling and on occasion, difficulty obtaining a signal. Prioritization of primary outcome measure was the goal.	ml/min^-1 dL^-1 mmHg^-1	MEAN
SECONDARY	Change in Minute Ventilation at Normoxia	baseline and 6 weeks		normoxia - L/min	MEAN
SECONDARY	Change in Minute Ventilation During Hypoxia	baseline and 6 weeks		hypoxia - L/min*%SaO2	MEAN
SECONDARY	Aortic Augmentation Index	baseline and 6 weeks	The number of participants differ between outcome measures due to difficulty in obtaining a viable signal for one outcome vs another and based on scheduling to prioritize the primary outcome measure.	PERCENT of the pulse pressure	MEAN
SECONDARY	Mean Change in PERCENT Vasodilation	baseline and 6 weeks	The number of participants differ between primary and secondary outcome variables due to occasional inability to obtain a viable signal for the variable and due to scheduling difficulties and prioritizing the primary outcome measure.	% change in Max relative FMD	MEAN
SECONDARY	Apnea-Hypopnea Index	baseline and 6 weeks	The number of participants differ between primary and secondary outcome variables due to occasional inability to obtain a viable signal for the variable and due to scheduling difficulties and prioritizing the primary outcome measure.	events/hour	MEDIAN
SECONDARY	PERCENT Time Spent Below 88 PERCENT Oxygen Saturation	baseline and 6 weeks	The number of participants differ between primary and secondary outcome variables due to occasional inability to obtain a viable signal for the variable and due to scheduling difficulties and prioritizing the primary outcome measure.	percentage of total sleep time	MEDIAN
SECONDARY	Change in Mean 24-Hour Blood Pressure (Mean Arterial Pressure)	baseline and 6 weeks	The number of participants differ between primary and secondary outcome variables due to occasional inability to obtain a viable signal for the variable and due to scheduling difficulties and prioritizing the primary outcome measure.	mm Hg	MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01637623/outcomes

API reference For AI assistants